{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:01:35Z","timestamp":1789070495161,"version":"build-2803163510"},"reference-count":30,"publisher":"BMJ","issue":"23","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2022,6,10]]},"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Diagnosis of cardiac sarcoidosis (CS) without histological evidence remains controversial. This study aimed to compare characteristics and outcomes of histologically proven versus clinically diagnosed cases of CS, which were adjudicated using Heart Rhythm Society or Japanese Circulation Society criteria.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A total of 512 patients with CS (age: 62\u00b111 years, female: 64.3%) enrolled in the multicentre registry were studied. Histologically confirmed patients were classified as \u2018biopsy-proven CS\u2019, while those with the presence of strongly suggestive clinical findings of CS without histological evidence were classified as \u2018clinical CS\u2019. Primary outcome was a composite of all-cause death, heart failure hospitalisation and ventricular arrhythmia event.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In total, 314 patients (61.3%) were classified as biopsy-proven CS, while 198 (38.7%) were classified as clinical CS. Patients classified under clinical CS were associated with higher prevalence of left ventricular dysfunction, septal thinning, and positive findings in fluorodeoxyglucose-positron emission tomography or Gallium scintigraphy than those under biopsy-proven CS. During median follow-up of 43.7 (23.3\u201377.3) months, risk of primary outcome was comparable between the groups (adjusted HR: 1.24, 95% CI: 0.88 to 1.75, p=0.22). Similarly, the risks of primary outcome were comparable between patients with clinical isolated CS who did not have other organ\/tissue involvement, and biopsy-proven isolated CS (adjusted HR: 1.23, 95% CI: 0.56 to 2.70, p=0.61).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>A substantial number of patients were diagnosed with clinical CS without confirmatory biopsy. Considering the worse clinical outcomes irrespective of the histological evidence, the diagnosis of clinical CS is justifiable if imaging findings suggestive of CS are observed.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/heartjnl-2022-320932","type":"journal-article","created":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T13:27:10Z","timestamp":1657027630000},"page":"1887-1894","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":26,"title":["Comparisons between biopsy-proven versus clinically diagnosed cardiac sarcoidosis"],"prefix":"10.1136","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2416-5865","authenticated-orcid":false,"given":"Takeshi","family":"Kitai","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan"},{"name":"Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital, Kobe, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeru","family":"Nabeta","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kitasato University School of Medicine, Sagamihara, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihisa","family":"Naruse","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, Hamamatsu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsunori","family":"Taniguchi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Suita, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Yoshioka","sequence":"additional","affiliation":[{"name":"Kameda Medical Center, Kamogawa, Chiba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chisato","family":"Miyakoshi","sequence":"additional","affiliation":[{"name":"Department of Research Support, Center for Clinical Research and Innovation, Kobe City Medical Center General Hospital, Kobe, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Kurashima","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaro","family":"Miyoshi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital, Kobe, Japan"},{"name":"Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidekazu","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Okumura","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Baba","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University, Kochi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Furukawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital, Kobe, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuya","family":"Matsue","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chisato","family":"Izumi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,7,5]]},"reference":[{"key":"2025091923174940000_108.23.1887.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)12888-7"},{"key":"2025091923174940000_108.23.1887.2","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-012-9358-3"},{"key":"2025091923174940000_108.23.1887.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2014.12.056"},{"key":"2025091923174940000_108.23.1887.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.06.038"},{"key":"2025091923174940000_108.23.1887.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.03.605"},{"key":"2025091923174940000_108.23.1887.6","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-14-1275"},{"key":"2025091923174940000_108.23.1887.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(99)70115-8"},{"key":"2025091923174940000_108.23.1887.8","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ahj.2020.02.008","article-title":"Performance of diagnostic criteria in patients clinically judged to have cardiac sarcoidosis: is it time to regroup?","volume":"223","author":"Ribeiro Neto","year":"2020","journal-title":"Am Heart J"},{"key":"2025091923174940000_108.23.1887.9","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cardfail.2021.06.016","article-title":"Sarcoidosis-related cardiomyopathy: current knowledge, challenges, and future perspectives state-of-the-art review","volume":"28","author":"Gilotra","year":"2022","journal-title":"J Card Fail"},{"key":"2025091923174940000_108.23.1887.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2014.03.043"},{"key":"2025091923174940000_108.23.1887.11","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1253\/circj.CJ-19-0508","article-title":"JCS 2016 Guideline on diagnosis and treatment of cardiac sarcoidosis\u2014Digest Version","volume":"83","author":"Terasaki","year":"2019","journal-title":"Circ J"},{"key":"2025091923174940000_108.23.1887.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.08.042"},{"key":"2025091923174940000_108.23.1887.13","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ijcard.2021.04.022","article-title":"Identification of a novel presumed cardiac sarcoidosis category for patients at high risk of disease","volume":"335","author":"Rosenbaum","year":"2021","journal-title":"Int J Cardiol"},{"key":"2025091923174940000_108.23.1887.14","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cpet.2018.12.004","article-title":"PET\/CT evaluation of cardiac sarcoidosis","volume":"14","author":"Bois","year":"2019","journal-title":"PET Clin"},{"key":"2025091923174940000_108.23.1887.15","article-title":"Evaluation of known or suspected cardiac sarcoidosis","volume":"9","author":"Blankstein","year":"2019","journal-title":"Circ Cardiovasc Imaging"},{"key":"2025091923174940000_108.23.1887.16","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1002\/ejhf.2018","article-title":"Standardized definitions for evaluation of heart failure therapies: scientific expert panel from the Heart Failure Collaboratory and Academic Research Consortium","volume":"22","author":"Abraham","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2025091923174940000_108.23.1887.17","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(97)70070-X"},{"key":"2025091923174940000_108.23.1887.18","doi-asserted-by":"publisher","DOI":"10.1253\/circj.67.490"},{"key":"2025091923174940000_108.23.1887.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2004.10.006"},{"key":"2025091923174940000_108.23.1887.20","doi-asserted-by":"publisher","DOI":"10.1378\/chest.14-0139"},{"key":"2025091923174940000_108.23.1887.21","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.115.003738"},{"key":"2025091923174940000_108.23.1887.22","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/j.hrthm.2015.06.032","article-title":"Comparison of cardiac MRI and 18F-FDG positron emission tomography manifestations and regional response to corticosteroid therapy in newly diagnosed cardiac sarcoidosis with complete heart block","volume":"12","author":"Orii","year":"2015","journal-title":"Heart Rhythm"},{"key":"2025091923174940000_108.23.1887.23","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2013-305187"},{"key":"2025091923174940000_108.23.1887.24","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)02715-8"},{"key":"2025091923174940000_108.23.1887.25","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.851352"},{"key":"2025091923174940000_108.23.1887.26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0238391","article-title":"Cardiac sarcoidosis: a long term follow up study","volume":"15","author":"Cacoub","year":"2020","journal-title":"PLoS One"},{"key":"2025091923174940000_108.23.1887.27","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.amjcard.2018.11.007","article-title":"Long-term outcome in probable versus absolute cardiac sarcoidosis","volume":"123","author":"Simonen","year":"2019","journal-title":"Am J Cardiol"},{"key":"2025091923174940000_108.23.1887.28","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.011522"},{"key":"2025091923174940000_108.23.1887.29","first-page":"385","article-title":"Prognosis and outcomes of clinically diagnosed cardiac sarcoidosis without positive endomyocardial biopsy findings","volume":"1","author":"Kusano","year":"2021","journal-title":"JACC: Asia"},{"key":"2025091923174940000_108.23.1887.30","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.intimp.2015.01.015","article-title":"Conventional markers in determination of activity of sarcoidosis","volume":"25","author":"Gungor","year":"2015","journal-title":"Int Immunopharmacol"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2022-320932","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T06:17:59Z","timestamp":1758349079000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2022-320932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,5]]},"references-count":30,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2022,11,10]]},"published-print":{"date-parts":[[2022,12]]}},"alternative-id":["10.1136\/heartjnl-2022-320932"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2022-320932","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,5]]}}}